Icosavax, Inc. (ICVX)
Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA.
Address
1930 BOREN AVE., SUITE 1000
SEATTLE, WA 98101
Founded
2017
Number of Employees
60
Website
http://www.icosavax.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at ICVX make a trade.
Creating a free account takes less than one minute